Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Abstract 3571: The ITCC-P4 sustainable platform of fully characterized PDXs supports the preclinical proof-of-concept drug testing of high-risk pediatric tumor models

Aniello Federico, Apurva Gopisetty, Didier Surdez, Yasmine Iddir, Alexandra Saint-Charles, Justyna Wierzbinska, Andreas Schlicker, Richard Volckmann, Danny Zwijnenburg, Sara Colombetti, Olaf Heidenreich, Fatima Iradier, Heinrich Kovar, Jan-Henning Klusmann, Klaus-Michael Debatin, Simon Bomken, Christina Guttke, Maureen M. Hattersley, Frédéric Colland, Ashley Strougo, María José Guillén, Louis Chesler, Chris Jones, Maria Eugénia Marques da Costa, Katia Scotlandi, Massimo Moro, Beat Schäfer, Marco Wachtel, Johannes Gojo, Walter Berger, Ángel Montero Carcaboso, Dennis Gürgen, Jens Hoffmann, Emilie Indersie, Stefano Cairo, Julia Schueler, Nicole Huebener, Johannes H. Schulte, Jan J. Molenaar, Birgit Geoerger, David J. Shields, Hubert N. Caron, Gilles Vassal, Lou F. Stancato, Lou F. Stancato, Stefan M. Pfister, Natalie Jäger, Jan Koster, Marcel Kool, Gudrun Schleiermacher

Cancer Res (2023) 83 (7_Supplement): 3571.

https://doi.org/10.1158/1538-7445.AM2023-3571

Published: 04 April 2023

View articletitled, Abstract 3571: The ITCC-P4 sustainable platform of fully characterized PDXs supports the preclinical proof-of-concept drug testing of high-risk pediatric tumor models

Journal Articles

Abstract 1667: Elimusertib shows stronger antitumor activity than standard of care chemotherapy in pediatric solid tumor models

Cancer Res (2023) 83 (7_Supplement): 1667.

https://doi.org/10.1158/1538-7445.AM2023-1667

Published: 04 April 2023

View articletitled, Abstract 1667: Elimusertib shows stronger antitumor activity than standard of care chemotherapy in pediatric solid tumor models

Journal Articles

Abstract 1693: Dissecting intercellular extrachromosomal circular DNA heterogeneity in single cancer cells with scEC&T-seq

Cancer Res (2022) 82 (12_Supplement): 1693.

https://doi.org/10.1158/1538-7445.AM2022-1693

Published: 15 June 2022

View articletitled, Abstract 1693: Dissecting intercellular extrachromosomal circular DNA heterogeneity in single cancer cells with scEC&T-seq

Journal Articles

Abstract A02: Patient-derived xenograft models of neuroblastoma as improvement for the prediction of targeted therapies for childhood cancer

Dennis Gürgen, Jana Rolff, Johannes H. Schulte, Hedwig E. Deubzer, Karin Schmelz, Anton G. Henssen, Patrick Hundsdörfer, Georg Seifert, Angelika Eggert, Wolfgang Walther, Jens Hoffmann

Cancer Res (2020) 80 (11_Supplement): A02.

https://doi.org/10.1158/1538-7445.CAMODELS2020-A02

Published: 02 June 2020

View articletitled, Abstract A02: Patient-derived xenograft models of neuroblastoma as improvement for the prediction of targeted therapies for childhood cancer

Journal Articles

Abstract 1820: Circular RNAs contribute to neuroblastoma pathogenesis

Filippos Klironomos, Clara Danssmann, Julian Naderi, Annika Winkler, Uschi Luz, Patrick Hundsdoerfer, Angelika Eggert, Joern Toedling, Falk Hertwig, Johannes H. Schulte, Steffen Fuchs

Cancer Res (2019) 79 (13_Supplement): 1820.

https://doi.org/10.1158/1538-7445.AM2019-1820

Published: 01 July 2019

View articletitled, Abstract 1820: Circular RNAs contribute to neuroblastoma pathogenesis

Journal Articles

Abstract 5679: Using droplet digital PCR to analyze MYCN copy number in plasma from patients with high-risk neuroblastoma

Marco Lodrini, Annika Sprüssel, Kathy Astrahantseff, Daniela Tiburtius, Robert Konschak, Holger Lode, Matthias Fischer, Johannes H. Schulte, Angelika Eggert, Hedwig Deubzer

Cancer Res (2017) 77 (13_Supplement): 5679.

https://doi.org/10.1158/1538-7445.AM2017-5679

Published: 01 July 2017

View articletitled, Abstract 5679: Using droplet digital PCR to analyze MYCN copy number in plasma from patients with high-risk neuroblastoma

Journal Articles

Abstract 3002: Therapeutic targeting of PGBD5-induced DNA repair dependence in pediatric solid tumors

Anton Henssen, Casie Reed, Eileen Jiang, Wong Wai, Elisa de Stanchina, Yasumichi Kuwahara, Hajime Hosoi, Johannes H. Schulte, Neil Ganem, John Petrini, Alex Kentsis

Cancer Res (2017) 77 (13_Supplement): 3002.

https://doi.org/10.1158/1538-7445.AM2017-3002

Published: 01 July 2017

View articletitled, Abstract 3002: Therapeutic targeting of PGBD5-induced DNA repair dependence in pediatric solid tumors

Journal Articles

WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma

Cancer Res (2015) 75 (23): 5143–5154.

https://doi.org/10.1158/0008-5472.CAN-15-0423

Published: 30 November 2015

View articletitled, WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma

Includes: Supplementary data

Journal Articles

Abstract 2980: Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Cancer Res (2015) 75 (15_Supplement): 2980.

https://doi.org/10.1158/1538-7445.AM2015-2980

Published: 01 August 2015

View articletitled, Abstract 2980: Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Journal Articles

Abstract LB-210: Telomerase activation by genomic rearrangements in high-risk neuroblastoma

Martin Peifer, Frederik Roels, Falk Hertwig, Roopika Menon, Andrea Kraemer, Reinhard Buettner, Sven Perner, Alexander Schramm, Johannes H. Schulte, Frank Westermann, Roman K. Thomas, Matthias Fischer

Cancer Res (2015) 75 (15_Supplement): LB-210.

https://doi.org/10.1158/1538-7445.AM2015-LB-210

Published: 01 August 2015

View articletitled, Abstract LB-210: Telomerase activation by genomic rearrangements in high-risk neuroblastoma

Journal Articles

Abstract 4731: Targeting super-enhancer induced gene expression with the novel BRD4 inhibitor OTX015 in preclinical models of MYCN-amplified neuroblastoma

Anton Henssen, Kristina Althoff, Richard Koche, Andrea Odersky, Anneleen Beckers, Frank Speleman, Simon Schäfers, Katleen De Preter, Alexandra Florin, Lukas Heukamp, Annika Spruessel, Kathy Astrahanseff, Natalie Sadowski, Alexander Schramm, Angelika Eggert, Lucile Astorgues-Xerri, Eugenia Riveiro, Esteban Cvitkovic, Johannes H. Schulte

Cancer Res (2015) 75 (15_Supplement): 4731.

https://doi.org/10.1158/1538-7445.AM2015-4731

Published: 01 August 2015

View articletitled, Abstract 4731: Targeting super-enhancer induced gene expression with the novel BRD4 inhibitor OTX015 in preclinical models of MYCN-amplified neuroblastoma

Journal Articles

Abstract B41: Whole genome sequencing identifies tumor evolution events in relapse neuroblastoma

Thomas F. Eleveld, Linda Schild, Jan Koster, Danny Zwijnenburg, Marli E. Ebus, Peter Sluis van, Johannes H. Schulte, Huib N. Caron, Rogier Versteeg, Jan J. Molenaar

Cancer Res (2014) 74 (20_Supplement): B41.

https://doi.org/10.1158/1538-7445.PEDCAN-B41

Published: 09 October 2014

View articletitled, Abstract B41: Whole genome sequencing identifies tumor evolution events in relapse neuroblastoma

Journal Articles

Abstract 3967: BET protein inhibitor OTX015 has selective anti-tumoral activity in preclinical models of MYCN- amplified neuroblastoma

Johannes H. Schulte, Kristina Althoff, Emma Bell, Andrea Odersky, Anneleen Beckers, Frank Speleman, Simon Schäfers, Alexander Schramm, Angelika Eggert, Frank Westermann, Eugenia Riveiro, Esteban Cvitkovic, Anton Henssen

Cancer Res (2014) 74 (19_Supplement): 3967.

https://doi.org/10.1158/1538-7445.AM2014-3967

Published: 01 October 2014

View articletitled, Abstract 3967: BET protein inhibitor OTX015 has selective anti-tumoral activity in preclinical models of MYCN- amplified neuroblastoma

Journal Articles

Abstract 4596: LIN28B drives neuroblastoma oncogenesis through let7-MYCN signaling.

Johannes H. Schulte, Jan Molenaar, Sven Lindner, Alexander Schramm, Pieter Mestdagh, Frank Speleman, Rogier Versteeg, Angelika Eggert

Cancer Res (2013) 73 (8_Supplement): 4596.

https://doi.org/10.1158/1538-7445.AM2013-4596

Published: 15 April 2013

View articletitled, Abstract 4596: LIN28B drives neuroblastoma oncogenesis through let7-MYCN signaling.

Journal Articles

Abstract 1438: Strong expression of CD57 is associated with aggressive neuroblastoma cells in vitro and in vivo, and with undifferentiated neuroblastoma cells in situ

Anne-Marie Schlitter, Carmen Dorneburg, Thomas F.E. Barth, Joachim Wahl, Johannes H. Schulte, Silke Brüderlein, Klaus-Michael Debatin, Christian Beltinger

Cancer Res (2012) 72 (8_Supplement): 1438.

https://doi.org/10.1158/1538-7445.AM2012-1438

Published: 15 April 2012

View articletitled, Abstract 1438: Strong expression of CD57 is associated with aggressive neuroblastoma cells in vitro and in vivo, and with undifferentiated neuroblastoma cells in situ

Journal Articles

Abstract 1683: ALK F1174L kinase activity as driver of cell proliferation in neuroblastoma cell line models and neuroblastoma tumors

Riet Hilhorst, Liesbeth Hovestad, Rik de Wijn, Dirk Pijnenburg, Rob Ruijtenbeek, Alexander Schramm, Angelika Eggert, Johannes H. Schulte

Cancer Res (2012) 72 (8_Supplement): 1683.

https://doi.org/10.1158/1538-7445.AM2012-1683

Published: 15 April 2012

View articletitled, Abstract 1683: ALK F1174L kinase activity as driver of cell proliferation in neuroblastoma cell line models and neuroblastoma tumors

Journal Articles

Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy

Johannes H. Schulte, Soyoung Lim, Alexander Schramm, Nicolaus Friedrichs, Jan Koster, Rogier Versteeg, Ingrid Ora, Kristian Pajtler, Ludger Klein-Hitpass, Steffi Kuhfittig-Kulle, Eric Metzger, Roland Schüle, Angelika Eggert, Reinhard Buettner, Jutta Kirfel

Cancer Res (2009) 69 (5): 2065–2071.

https://doi.org/10.1158/0008-5472.CAN-08-1735

Published: 02 March 2009

View articletitled, Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy

Includes: Supplementary data

Journal Articles

Differential Effects of TrkA or TrkB Expression on DNA Repair Capacity Might Contribute to the Genomic Stability of SY5Y Neuroblastoma Cells

Johannes H. Schulte, Steffi Kuhfittig-Kulle, Daniela Dobrzinski, Alexander Schramm, Elke Feldmann, Ludger Klein-Hitpass, Harald Stephan, Werner Havers, Petra Pfeiffer, Angelika Eggert

Cancer Res (2005) 65 (9_Supplement): 689–690.

Published: 01 May 2005

View articletitled, Differential Effects of TrkA or TrkB Expression on DNA Repair Capacity Might Contribute to the Genomic Stability of SY5Y Neuroblastoma Cells

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 3571: The ITCC-P4 sustainable platform of fully characterized PDXs supports the preclinical proof-of-concept drug testing of high-risk pediatric tumor models

Abstract 1667: Elimusertib shows stronger antitumor activity than standard of care chemotherapy in pediatric solid tumor models

Abstract 1693: Dissecting intercellular extrachromosomal circular DNA heterogeneity in single cancer cells with scEC&T-seq

Abstract A02: Patient-derived xenograft models of neuroblastoma as improvement for the prediction of targeted therapies for childhood cancer

Abstract 1820: Circular RNAs contribute to neuroblastoma pathogenesis

Abstract 5679: Using droplet digital PCR to analyze MYCN copy number in plasma from patients with high-risk neuroblastoma

Abstract 3002: Therapeutic targeting of PGBD5-induced DNA repair dependence in pediatric solid tumors

WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma

Abstract 2980: Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Abstract LB-210: Telomerase activation by genomic rearrangements in high-risk neuroblastoma

Abstract 4731: Targeting super-enhancer induced gene expression with the novel BRD4 inhibitor OTX015 in preclinical models of MYCN-amplified neuroblastoma

Abstract B41: Whole genome sequencing identifies tumor evolution events in relapse neuroblastoma

Abstract 3967: BET protein inhibitor OTX015 has selective anti-tumoral activity in preclinical models of MYCN- amplified neuroblastoma

Abstract 4596: LIN28B drives neuroblastoma oncogenesis through let7-MYCN signaling.

Abstract 1438: Strong expression of CD57 is associated with aggressive neuroblastoma cells in vitro and in vivo, and with undifferentiated neuroblastoma cells in situ

Abstract 1683: ALK F1174L kinase activity as driver of cell proliferation in neuroblastoma cell line models and neuroblastoma tumors

Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy

Differential Effects of TrkA or TrkB Expression on DNA Repair Capacity Might Contribute to the Genomic Stability of SY5Y Neuroblastoma Cells

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only